ClinicalTrials.gg
CompletedNCT03514342Updated Jun 18, 2021

The Effects of Horner's Syndrome Developing After Interscalene Brachial Plexus Block on Autonomic Nervous Activity

An observational study in Brachial Plexus Block, Horner Syndrome and Autonomic Imbalance, sponsored by Daegu Catholic University Medical Center. Completed at 1 site in Korea, Republic of. Open to participants aged 20 Years to 60 Years. Per ClinicalTrials.gov, last updated 2021-06-18.

Sponsored by Daegu Catholic University Medical Center · Observational

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
48
Ages
20 Years to 60 Years
Sex
All
01

Study summary

This study evaluates the effects of Horner's syndrome on cardiac autonomic nervous activity after interscalene brachial plexus block. Cardiac autonomic nervous activity and bilateral pupil diameters will be measured in a scotopic light condition, 30 minutes after interscalene brachial plexus block under ultrasound guidance and 15 minutes after the subsequent sitting position.

Read the detailed description

Stellate ganglia provide sympathetic fibers to the heart. Ipsilateral stellate ganglion block accompanied by interscalene brachial plexus block causes Horner's syndrome presenting with miosis, ptosis, and anhidrosis. The extent of Horner's syndrome can be represented by the difference in pupil diameter between bilateral eyes. Cardiac autonomic nervous activity affected by stellate ganglion block can be measured by calculation of heart rate variability parameters.

02

Conditions studied

  • Brachial Plexus Block
  • Horner Syndrome
  • Autonomic Imbalance

Keywords

  • Heart rate variability
  • Mesopic pupil size
03

In context

Lead sponsor

Daegu Catholic University Medical Center is the lead sponsor of 28 studies on the registry; 1 is open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
20 Years to 60 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Tertiary hospital

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • physical status 1
  • Arthroscopic shoulder surgery under interscalene brachial plexus block

Exclusion criteria

Exclusion Criteria:

  • Coagulopathy
  • Infection at the site of brachial plexus block
  • Peripheral neuropathy or neurologic sequelae on the operative limb
  • Allergy to local anesthetics or history of allergic shock
  • Psychiatric diseases
  • Patient refusal
  • Difficulty communicating with medical personnel
  • Arrhythmias
  • Ischemic heart disease
  • Hypertension
  • Diabetes mellitus
  • Thyroid dysfunction
  • Conduction abnormalities on
  • Electrolyte imbalance
  • Medications affecting cardiac conduction
  • Contralateral vocal cord palsy
  • Contralateral hemidiaphragmatic paresis or paralysis
  • Contralateral pneumothorax or hemothorax
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

ASA physical status

The anaesthetists’ scale of health before surgery: I is healthy, II has a mild illness that is under control, III a severe one, IV a severe illness that is a constant threat to life. V and VI are used for the critically ill and for organ donors.

ECG (electrocardiogram)

A recording of the heart’s electrical activity, taken with stickers on the chest, arms and legs. It takes a few minutes and does not hurt.

05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
48 participants (actual)
Patient registry
No

Groups and cohorts

  • Interscalene brachial plexus block

    Ultrasound-guided interscalene brachial plexus block with 25 ml to 30 ml of 0.75% ropivacaine

    Procedure: Interscalene brachial plexus block · Drug: 0.75% ropivacaine

Interventions

  • ProcedureInterscalene brachial plexus block

    Under ultrasound guidance, the 5th to 7th cervical nerve roots are identified between anterior and middle scalene muscles and subsequently blocked.

  • Placement of 25 to 30 ml of 0.75% ropivacaine around the 5th to 7th cervical nerve roots

    Also known as: Naropin

06

What researchers measure

Primary outcomes

  1. Post-sitting sympathetic nervous activity

    Natural-log transformed low frequency power of heart rate variability calculated using R wave to R wave intervals obtained for 5 minutes between 10 and 15 minutes after the sitting position following interscalene brachial plexus block

    Time frame: 15 minutes after the sitting position following interscalene brachial plexus block

Secondary outcomes

  1. Post-sitting ipsilateral pupil diameter

    Ipsilateral pupil diameter measured under a mesopic condition 15 minutes after the sitting position following interscalene brachial plexus block

    Time frame: 15 minutes after the sitting position following interscalene brachial plexus block

  2. Post-sitting contralateral pupil diameter

    Contralateral pupil diameter measured under a mesopic condition 15 minutes after the sitting position following interscalene brachial plexus block

    Time frame: 15 minutes after the sitting position following interscalene brachial plexus block

  3. Post-anesthetic ipsilateral pupil diameter

    Ipsilateral pupil diameter measured under a mesopic condition 30 minutes after interscalene brachial plexus block

    Time frame: 30 minutes after interscalene brachial plexus block

  4. Post-anesthetic contralateral pupil diameter

    Contralateral pupil diameter measured under a mesopic condition 30 minutes after interscalene brachial plexus block

    Time frame: 30 minutes after interscalene brachial plexus block

  5. Pre-anesthetic ipsilateral pupil diameter

    Ipsilateral pupil diameter measured under a mesopic condition 15 minutes after baseline acclimation

    Time frame: 15 minutes after baseline acclimation

  6. Pre-anesthetic contralateral pupil diameter

    Contralateral pupil diameter measured under a mesopic condition 15 minutes after baseline acclimation

    Time frame: 15 minutes after baseline acclimation

  7. Post-sitting parasympathetic nervous activity

    Natural-log transformed high frequency power of heart rate variability calculated using R wave to R wave intervals obtained for 5 minutes between 10 and 15 minutes after the sitting position following interscalene brachial plexus block

    Time frame: 15 minutes after the sitting position following interscalene brachial plexus block

  8. Post-sitting sympathovagal balance

    Low-to-high frequency power ratio of heart rate variability obtained for 5 minutes between 10 and 15 minutes after the sitting position following interscalene brachial plexus block

    Time frame: 15 minutes after the sitting position following interscalene brachial plexus block

  9. Post-sitting overall variability of autonomic nervous system

    Natural-log transformed total power of heart rate variability obtained for 5 minutes between 10 and 15 minutes after the sitting position following interscalene brachial plexus block

    Time frame: 15 minutes after the sitting position following interscalene brachial plexus block

  10. Post-anesthetic sympathetic nervous activity

    Natural-log transformed low frequency power of heart rate variability between 25 and 30 minutes after interscalene brachial plexus block

    Time frame: Between 25 and 30 minutes after interscalene brachial plexus block

  11. Post-anesthetic parasympathetic nervous activity

    Natural-log transformed high frequency power of heart rate variability between 25 and 30 minutes after interscalene brachial plexus block

    Time frame: Between 25 and 30 minutes after interscalene brachial plexus block

  12. Post-anesthetic sympathovagal balance

    Low-to-high frequency power ratio of heart rate variability between 25 and 30 minutes after interscalene brachial plexus block

    Time frame: Between 25 and 30 minutes after interscalene brachial plexus block

  13. Post-anesthetic overall variability of autonomic nervous system

    Natural-log transformed total power of heart rate variability between 25 and 30 minutes after interscalene brachial plexus block

    Time frame: Between 25 and 30 minutes after interscalene brachial plexus block

  14. Pre-anesthetic sympathetic nervous activity

    Natural-log transformed low frequency power of heart rate variability 15 minutes after baseline acclimation

    Time frame: 15 minutes after baseline acclimiation

  15. Pre-anesthetic parasympathetic nervous activity

    Natural-log transformed high frequency power of heart rate variability 15 minutes after baseline acclimation

    Time frame: 15 minutes after baseline acclimiation

  16. Pre-anesthetic sympathovagal balance

    Low-to-high frequency power ratio of heart rate variability 15 minutes after baseline acclimation

    Time frame: 15 minutes after baseline acclimiation

  17. Pre-anesthetic overall variability of autonomic nervous system

    Natural-log transformed total power of heart rate variability 15 minutes after baseline acclimation

    Time frame: 15 minutes after baseline acclimation

  18. Sensory blockade

    C5 to T1 dermatomal blockade of the shoulder graded from 0 to 2 (0 = no cold sensation, 1 = reduced cold sensation, and 2 = normal cold sensation) by applying ice to the shoulder

    Time frame: 30 minutes after interscalene brachial plexus block

  19. Motor blockade

    Motor blockade of the radial, ulnar, median, musculocutaneous, and axillary nerves graded from 0 to 2 (0 = no block 1 = partial block, and 2 = complete block)

    Time frame: 30 minutes after interscalene brachial plexus block

07

Study locations

1 site
  • Daegu Catholic University Medical Center
    Daegu, 42472, Korea, Republic of
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Ran from Jun 2018 to primary completion in Jul 2019, 12 months.

How these figures are worked out, and which studies are left out of them.

Registered
Apr 19, 2018
First posted
May 2, 2018
StartActual
Jun 18, 2018
Primary completionActual
Jul 1, 2019
CompletionActual
Jul 1, 2019
Last update
Jun 18, 2021
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jun 18, 2021, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03514342
Lead sponsor
Daegu Catholic University Medical Center
Collaborators
Research Institute of Medical Science, Daegu Catholic University
Responsible party
JongHae Kim (Associate Professor, Daegu Catholic University Medical Center) — Principal investigator
First posted
May 2, 2018
Start date
Jun 18, 2018
Primary completion
Jul 1, 2019
Completion
Jul 1, 2019
Last update
Jun 18, 2021

Study contacts

Jong Hae Kim, MD
principal investigator · Daegu Catholic University Medical Center

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jun 2021. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion